Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
5 Sep 2025
GLP-1 RAs May Halve Risk of Peptic Ulcer in Type 2 Diabetes
Learn how GLP-1 RAs may cut peptic ulcer risk in diabetes patients by nearly half.
5 Sep 2025
Omalizumab Shows Promise for Treating Chronic Urticaria in Children
Learn how omalizumab shows high response rates and low side effects in children with chronic spontaneous urticaria.
15
Mins
5 Sep 2025
Sponsored content: ADC-IO combination in comorbid patients with advanced urothelial cancer
This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…
September 2025
EMJ Oncology 13 [Supplement 4] 2025
Sponsored Content: This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…
4 Sep 2025
Chronic Liver Disease Remains Major Health Burden
The team concluded that CLD remains a major health burden in Thailand, highlighting the need for strong prevention strategies, early diagnosis, and equitable access to effective therapies.
4 Sep 2025
Mini-Camera and AI Accurately Predict Heart Attack Recurrence
AI and imaging mini-cameras now reliably predict future heart attack risk, paving the way for more targeted treatment.
4 Sep 2025
High Ischaemic Deficit Signals Stroke Risk in Takayasu Arteritis
A prospective study highlights that Takayasu arteritis patients with high ischemic deficits on CT perfusion scans face a sharply elevated risk of strokes and other ischemic events.
4 Sep 2025
Medical Cannabis Improves Sleep and Mood in Patients with Insomnia
Medical cannabis linked to better sleep, mood, and life quality in insomnia patients over 18 months, real-world study finds.
MSD strikes $10bn deal for Verona Pharma
MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care portfolio.
4 Sep 2025
Do Older Childhood Cancer Survivors Face Higher Health Risks?
Survivors of childhood cancer who live past age 50 face a significantly higher risk of premature death and serious health problems compared with the general population…
←
1
2
3
…
100
101
102
103
104
105
106
…
1,325
1,326
1,327
→
We’ve noticed you’re accessing
from
North/South America.
View
View